3-氟-4-甲苯基-1-羰基咪唑胺盐酸盐 | 238742-80-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氟-4-甲苯基-1-羰基咪唑胺盐酸盐
• 中文别名: 3-氟-4-甲基苯甲酰胺肟
• 英文名称: 3-fluoro-N'-hydroxy-4-methylbenzenecarboximidamide
• 英文别名: 3-fluoro-N'-hydroxy-4-methylbenzamidine；3-fluoro-N′-hydroxy-4-methylbenzimidamide；3-fluoro-N'-hydroxy-4-methylbenzimidamide；3-Fluoro-4-methylbenzamide oxime
• CAS: 238742-80-8
• 化学式: C₈H₉FN₂O
• mdl: MFCD00673178
• 分子量: 168.171
• InChiKey: RCNTZYAQXVFCBQ-UHFFFAOYSA-N

物化性质

• 熔点：
  105-107°C
• 沸点：
  261.7±50.0 °C(Predicted)
• 密度：
  1.25±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2925290090
• 安全说明：
  S26,S36/37/39

SDS

Name:	3-Fluoro-N -hydroxy-4-methylbenzenecarboximidamide Material Safety Data Sheet
Synonym:	None know
CAS:	238742-80-8

Section 1 - Chemical Product MSDS Name:3-Fluoro-N -hydroxy-4-methylbenzenecarboximidamide Material Safety Data Sheet
Synonym:None know

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
238742-80-8	3-Fluoro-N'-hydroxy-4-methylbenzenecar	95+%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38 44

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin. Risk of explosion if heated under confinement.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Violently decomposes when heated under confinement.
Risk of explosion if heated under confinement.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions.

---

Section 7 - HANDLING and STORAGE
Handling:
Use with adequate ventilation. Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 238742-80-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Off white
Odor: Without to slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 105 - 107 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H9FN2O
Molecular Weight: 168.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents, strong acids, acid chlorides.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 238742-80-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Fluoro-N'-hydroxy-4-methylbenzenecarboximidamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 44 Risk of explosion if heated under confinement.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 238742-80-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 238742-80-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 238742-80-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氟-4-甲苯基-1-羰基咪唑胺盐酸盐 在 盐酸 、 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 、 sodium hydride 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 四氯化碳 、 正丁醇 为溶剂， 反应 48.5h， 生成 N-(2-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-6-(1-fluoroethyl)pyrimidin-4-amine
  参考文献：
  名称：

  带有 5-(三氟甲基)-1,2,4-恶二唑部分的嘧啶-4-胺衍生物的设计、合成和杀虫活性

  摘要：

  由于农药耐药性的不断演变，发现具有新作用模式的新农药非常重要。在这项研究中，设计并合成了一系列含有 5-(三氟甲基)-1,2,4-恶二唑部分的新型嘧啶-4-胺衍生物。它们的结构经1 H NMR、13 C NMR 和 HRMS证实。生物测定表明，化合物29对合成具有优异的杀虫活性粘虫，蚜虫medicagini，和朱砂叶螨和杀真菌活性抗霜霉病。在这些嘧啶-4-胺类化合物中，5-氯-N-(2-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-6-(1-fluoroethyl)pyrimidin-4-amine ( U7 ) and 5-bromo- N -(2-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)-6-(1-fluoroethyl)pyrimidin-4-amine(

  DOI：

  10.1021/acs.jafc.1c00236
• 作为产物：
  描述：

  3-氟-4-甲基苯腈 在 羟胺 作用下， 以 乙醇 、 水 为溶剂， 反应 0.33h， 以91.6%的产率得到3-氟-4-甲苯基-1-羰基咪唑胺盐酸盐
  参考文献：
  名称：

  Novel Alpha-(N-Sulfonamido)Acetamide Compound as an Inhibitor of Beta Amyloid Peptide Production

  摘要：

  本发明提供了一种新型的α-(N-磺胺基)乙酰胺化合物，其药物组合物，其制备方法以及用于治疗阿尔茨海默病和其他与β-淀粉样肽相关疾病的方法。

  公开号：

  US20090111858A1

文献信息

• [EN] FUNGICIDAL COMPOSITIONS<br/>[FR] COMPOSITIONS FONGICIDES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2018219773A1

  公开（公告）日：2018-12-06

  A fungicidal composition comprising a mixture of components (A) and (B), wherein components (A) and (B) are as defined in claim 1, and use of the compositions in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.

  一种含有成分（A）和（B）混合物的杀菌组合物，其中成分（A）和（B）如权利要求1中所定义，以及将该组合物用于农业或园艺中，用于控制或预防植物被植物病原微生物，尤其是真菌的侵害。
• [EN] PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE<br/>[FR] PIPÉRIDINYLPYRAZOLOPYRIMIDINONES ET LEUR UTILISATION
  申请人：BAYER PHARMA AG

  公开号：WO2016071216A1

  公开（公告）日：2016-05-12

  The present application relates to novel substituted piperidinylpyrazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired hemostatic disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of heavy menstrual bleeding, postpartum hemorrhage, hemorrhagic shock, hemorrhagic cystitis, gastrointestinal hemorrhage, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.

  本申请涉及新型取代哌啶基吡唑吡嘧啶酮，以及它们的制备方法，这些化合物可单独或组合使用于治疗和/或预防疾病的方法中，特别是用于治疗和/或预防患有或不患有基础遗传或获得性止血障碍的患者的急性和复发性出血，其中出血与从重经期出血、产后出血、出血性休克、出血性膀胱炎、胃肠道出血、创伤、手术、移植、中风、肝脏疾病、遗传性血管性水肿、鼻血、以及血液积聚后的滑膜炎和软骨损伤等一组疾病或医疗干预有关。
• 哌啶类化合物及其制备方法和医药用途
  申请人：中国药科大学

  公开号：CN112608320B

  公开（公告）日：2023-03-17

  本发明公开了如式(I)所示的哌啶类化合物及其制备方法和医药用途，具体是指哌啶类USP7抑制剂化合物或其药学上可接受的盐或酯或溶剂化物及制备方法和用途，本发明的化合物能抑制USP7酶的活性，同时具有非常好的选择性和成药性，可以用于制备预防或治疗肿瘤疾病或病毒感染性疾病的药物。
• One Base for Two Shots: Metal-Free Substituent-Controlled Synthesis of Two Kinds of Oxadiazine Derivatives from Alkynylbenziodoxolones and Amidoximes
  作者：Ming Li、Wei Li、Cheng-Dong Lin、Jia-Hui Wang、Li-Rong Wen

  DOI：10.1021/acs.joc.9b00659

  日期：2019.6.7

  2-migrations and cyclizations of a variety of alkynylbenziodoxolones (EBXs) and amidoximes under one-base conditions are described. This process provides an efficient protocol for the divergent synthesis of two oxadiazine derivatives via switchable selectivity of EBXs controlled by simply varying the substituents of the amidoximes, which feature transition metal-free conditions, simple execution, and high

  描述了在一个碱基条件下，各种炔基苯并恶唑酮（EBXs）和ox胺肟的不同的1,2-迁移和环化。该方法为通过简单地改变the胺肟的取代基而控制的EBX的选择性切换提供了一种有效的方案，用于二恶二嗪衍生物的多样化合成，其特征在于无过渡金属的条件，简单的操作和高的化学选择性。
• NOVEL ALPHA-(N-SULFONAMIDO)ACETAMIDE COMPOUNDS INCORPORATING DEUTERIUM AS INHIBITORS OF BETA AMYLOID PEPTIDE PRODUCTION
  申请人：Starrett, JR. John E.

  公开号：US20100240719A1

  公开（公告）日：2010-09-23

  The present disclosure provides novel deuterated alpha-(N-sulfonamido)acetamide compounds, their pharmaceutical composition, processes thereof and a method for the treatment of Alzheimer's disease, head trauma, traumatic brain injury, and/or dementia pugilistica and/or other conditions associated with β-amyloid peptide.

  本公开提供了新型的氘代α-(N-磺胺基)乙酰胺化合物，它们的药物组合物，其制备方法以及治疗阿尔茨海默病、头部创伤、创伤性脑损伤、老年痴呆症以及与β-淀粉样肽相关的其他疾病的方法。